MacroGenics
$31.169876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$31.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.39 (-1.24%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours
Why Robinhood?
You can buy or sell MacroGenics and other stocks, options, and ETFs commission-free!
About MGNX
MacroGenics, Inc. Common Stock, also called MacroGenics, is a clinical-stage biopharmaceutical company, which engages in discovering and developing antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer.
CEO
Scott E. Koenig
Employees
370
Headquarters
Rockville, Maryland
Founded
2000
Market Cap
1.89B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
504.26K
High Today
$31.57
Low Today
$30.65
Open Price
$31.57
Volume
527.96K
52 Week High
$33.61
52 Week Low
$5.00
Analyst Ratings
82%
of 11 ratings
Buy
82%
Hold
9%
Sell
9%
MGNX Earnings
-$1.02
-$0.67
-$0.33
$0.02
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, After Hours